The American Psychiatric Association defines eating disorders as, “behavioral conditions characterized by severe and persistent disturbance in eating behaviors and associated distressing thoughts and emotions.” Eating disorders affect 28 million people in the US. The most common are anorexia, bulimia, and binging. Medical interventions are frequently necessary due to a combination of malnutrition and co-occurring disorders such as addiction, alcohol use disorder, depression, and obsessive compulsive disorder (OCD).
There are several possible causes of eating disorders. The eating disorder often begins as an unhealthy body image coupled with an insatiable desire to fit into a particular social grouping. Although some eating disorders may have genetic factors involved in their origin, personality traits and social pressures play a much larger role in their development. Young people are the highest risk category for eating disorders; bulimia and anorexia are most common in those 18 years old, and binging is most common in young adults around 21 years of age.
Daytryp specializes in harnessing the power of psychedelic therapies as highly effective and scientifically supported treatment options for individuals struggling with eating disorders. Our approach offers new possibilities, particularly for those who have faced challenges with traditional treatments. With a compassionate and knowledgeable team, we guide each client on a transformative healing journey.
Under the careful medical supervision of our experts, our mission is to help you unlock your potential by utilizing psychedelic therapies to address the underlying factors contributing to eating disorders and cultivate healthier relationships with food and body image. We provide the necessary resources and support to empower you in making lasting changes that promote healing, self-acceptance, and a balanced approach to nourishing your mind and body.
Researchers discovered nearly two-thirds of participants with treatment-resistant Anorexia Nervosa who received multiple ketamine infusions, combined with an opioid-blocking medication, saw a complete elimination of their compulsive thought patterns. And more than 50% returned to behaviors of healthier eating for a long period after their discharge from the hospital. This makes ketamine one of the most effective treatments for eating disorders available to patients.
3,4-methylenedioxy-methamphetamine (MDMA) therapy is an upcoming, highly effective and innovative treatment approach for those suffering from post-traumatic stress disorder (PTSD) and other mental health conditions. It combines the psychoactive compound MDMA with guided psychological support, and has shown as much as a 75% success rate in patients suffering from PTSD, setting an unprecedented standard for treatment. MDMA therapy is not currently available, but expected to gain FDA approval later this year.